We are live on ! Find out more
BC

Blackhill Capital Portfolio holdings

AUM $1.94B
1-Year Est. Return 18.09%
This Fund
S&P 500
This Quarter Est. Return
+3.91%
1 Year Est. Return
+18.09%
3 Year Est. Return
+164.47%
5 Year Est. Return
+136.25%
10 Year Est. Return
+688.12%
AUM
$896M
AUM Growth
+$33.1M
Cap. Flow
+$5.22M
Cap. Flow %
0.58%
Top 10 Hldgs %
86.92%
Holding
52
New
Increased
4
Reduced
7
Closed

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$6.62M
2
MRK icon
Merck
MRK
+$918K
3
ABBV icon
AbbVie
ABBV
+$566K
4
MMP
Magellan Midstream Partners, L.P.
MMP
+$42.4K

Top Sells

Rank Stock Value
1
ZTS icon
Zoetis
ZTS
+$1.64M
2
LLY icon
Eli Lilly
LLY
+$506K
3
WSM icon
Williams-Sonoma
WSM
+$484K
4
BMY icon
Bristol-Myers Squibb
BMY
+$254K
5
ZBH icon
Zimmer Biomet
ZBH
+$25.1K

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 53.95%
2 Healthcare 29.96%
3 Technology 7.19%
4 Communication Services 2.16%
5 Consumer Staples 1.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WSM icon
1
Williams-Sonoma
WSM
$29.5B
$480M 53.61%
7,894,994
-7,746
-0.1% -$484K
LLY icon
2
Eli Lilly
LLY
$1.08T
$50M 5.58%
145,633
-1,500
-1% -$506K
AAPL icon
3
Apple
AAPL
$4.45T
$43.4M 4.84%
263,000
ABBV icon
4
AbbVie
ABBV
$442B
$42M 4.68%
263,260
+3,700
+1% +$566K
JNJ icon
5
Johnson & Johnson
JNJ
$626B
$30.8M 3.44%
198,850
+41,020
+26% +$6.62M
ABT icon
6
Abbott
ABT
$190B
$30.5M 3.4%
301,230
BMY icon
7
Bristol-Myers Squibb
BMY
$130B
$30.3M 3.38%
437,264
-3,600
-0.8% -$254K
ZTS icon
8
Zoetis
ZTS
$31.1B
$26.7M 2.99%
160,714
-10,000
-6% -$1.64M
MRK icon
9
Merck
MRK
$322B
$23.9M 2.67%
225,100
+8,500
+4% +$918K
MSFT icon
10
Microsoft
MSFT
$3.74T
$20.8M 2.32%
72,050
DIS icon
11
Walt Disney
DIS
$179B
$15.7M 1.75%
156,300
CAT icon
12
Caterpillar
CAT
$388B
$13.7M 1.53%
60,000
PFE icon
13
Pfizer
PFE
$152B
$13.1M 1.46%
320,301
ZBH icon
14
Zimmer Biomet
ZBH
$18.5B
$10.7M 1.2%
82,950
-200
-0.2% -$25.1K
KMB icon
15
Kimberly-Clark
KMB
$36.1B
$9.53M 1.06%
71,000
MA icon
16
Mastercard
MA
$492B
$7.27M 0.81%
20,000
BRK.B icon
17
Berkshire Hathaway Class B
BRK.B
$1.11T
$6.72M 0.75%
21,748
PG icon
18
Procter & Gamble
PG
$338B
$6.67M 0.74%
44,871
CI icon
19
Cigna
CI
$72.4B
$5.57M 0.62%
21,779
EPD icon
20
Enterprise Products Partners
EPD
$81.8B
$2.82M 0.31%
108,704
-946
-0.9% -$24.3K
BRK.A icon
21
Berkshire Hathaway Class A
BRK.A
$1.11T
$2.79M 0.31%
6
MMP
22
DELISTED
Magellan Midstream Partners, L.P.
MMP
$2.15M 0.24%
39,600
+800
+2% +$42.4K
AMZN icon
23
Amazon
AMZN
$2.94T
$2.08M 0.23%
20,100
MDT icon
24
Medtronic
MDT
$116B
$1.95M 0.22%
24,177
CVX icon
25
Chevron
CVX
$386B
$1.88M 0.21%
11,550

Similar funds

Blackhill Capital's Q1 2023 Portfolio in Review

As of Q1 2023, Blackhill Capital held 52 positions worth $896M, up 3.8% from $863M the previous quarter. Its ten largest holdings account for 87% of the portfolio.

Trading was light in Q1 2023: portfolio turnover was 0%. Blackhill Capital opened no new positions and made no exits, leaving the 52-position portfolio largely intact.

By sector, the portfolio is most concentrated in Consumer Discretionary at 54% of assets, up from 53% a quarter earlier, followed by Healthcare and Technology.

  • Blackhill Capital added most to Johnson & Johnson in Q1 2023, an estimated $6.62M increase.
  • Blackhill Capital's biggest Q1 2023 reduction was Zoetis, cutting an estimated $1.64M.
  • Blackhill Capital's ten largest holdings make up 87% of its $896M portfolio in Q1 2023.
  • Blackhill Capital opened 0 new positions and closed 0 in Q1 2023.
  • Blackhill Capital's portfolio value rose 3.8% quarter-over-quarter to $896M.

Based on Blackhill Capital's 13F filing for Q1 2023, filed 12 May 2023.